Caligan Partners LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
CP Caligan Partners LP | Institutional Filer | ▲ 18.68% | $1.44B | 24 |
Current Portfolio Holdings
Showing all 24 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | LQDA | Liquidia Corporation | Healthcare | 8.1M | $306.4M | 21.30% |
| 2 | RVMD | Revolution Medicines, Inc. | Healthcare | 1.9M | $183.0M | 12.72% |
| 3 | ABVX | Abivax S.A. | Healthcare | 1.5M | $162.8M | 11.31% |
| 4 | PCVX | Vaxcyte, Inc. | Healthcare | 2.1M | $119.7M | 8.32% |
| 5 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 1.4M | $81.0M | 5.63% |
| 6 | MLYS | Mineralys Therapeutics, Inc. | Healthcare | 2.8M | $75.1M | 5.22% |
| 7 | EXEL | Exelixis, Inc. | Healthcare | 1.6M | $66.6M | 4.63% |
| 8 | TNGX | Tango Therapeutics, Inc. | Healthcare | 2.4M | $50.4M | 3.50% |
| 9 | TYRA | Tyra Biosciences, Inc. | Healthcare | 1.3M | $48.9M | 3.40% |
| 10 | ADMA | ADMA Biologics, Inc. | Healthcare | 5.1M | $45.6M | 3.17% |
| 11 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 878K | $44.3M | 3.08% |
| 12 | LBRX | LB Pharmaceuticals Inc Common Stock | Healthcare | 1.4M | $34.6M | 2.41% |
| 13 | VOR | Vor Biopharma Inc. | Healthcare | 1.9M | $34.3M | 2.39% |
| 14 | SABS | SAB Biotherapeutics, Inc. | Healthcare | 8.0M | $30.5M | 2.12% |
| 15 | IRD | Opus Genetics, Inc. | Healthcare | 6.1M | $27.6M | 1.92% |
Showing 1 to 15 of 24 holdings